Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke

BACKGROUND: There is increasing interest in stem cell therapy as another treatment modality in stroke, particularly for patients who are unable to receive endovascular clot retrieval or thrombolysis therapies, or for whom standard treatment has failed. We have recently shown that human amniotic epit...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Thanh G., Ma, Henry, Lim, Rebecca, Sobey, Christopher G., Wallace, Euan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999782/
https://www.ncbi.nlm.nih.gov/pubmed/29930530
http://dx.doi.org/10.3389/fneur.2018.00198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999782/
https://www.ncbi.nlm.nih.gov/pubmed/29930530
http://dx.doi.org/10.3389/fneur.2018.00198

Ejemplares similares